Every month, the FDA reviews dozens of medical devices, but only a handful earn approval. This month, three devices stand out because they address common proble
I have spent two decades in oncology, watching treatments evolve from blunt chemotherapy to more targeted approaches. But nothing has prepared me for what we ar
Every month, the FDA reviews dozens of new medical devices, but only a few truly stand out as game-changers for patients. This month, three approvals caught my
I have spent two decades caring for patients with cancer, and I can tell you that 2026 will be remembered as a year when hope turned into tangible progress. The
After two decades in medicine, I have watched telemedicine grow from a rare convenience to a daily necessity. But with that growth comes change, and the latest
For decades, the phrase "rare disease" often meant a lifetime of uncertainty, limited treatment options, and a search for answers that felt like a lonely journe
For decades, the term "rare disease" often meant a lifetime of uncertainty, limited treatment options, and a heavy emotional burden. But today, I am witnessing
I have spent two decades practicing medicine, and I can tell you without hesitation that the most exciting change I have witnessed is the arrival of artificial
For decades, a diagnosis of a rare disease often felt like a dead end. Many of these conditions, affecting fewer than 200,000 people in the United States, have
Over the past two decades, I have watched the field of medicine transform in ways that once seemed like science fiction. But nothing has moved me more than the
I have spent two decades in practice, watching technology evolve from paper charts to electronic records. But nothing has prepared me for the transformation I a
After two decades in practice, I have watched telemedicine evolve from a niche service into a mainstream way patients connect with their doctors. But with that